Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Misoprostol for fetal death at 14-28 weeks
NCT00671060Phase 3Completed
- Sponsor
- Gynuity Health Projects
- Start
- Oct 2008
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial of misoprostol in intrauterine fetal demise (IUFD) (2 arms), sponsored by Gynuity Health Projects. Primary endpoint: Successful Expulsion of Fetus and Placenta Within 48 Hours. Started Oct 2008; status: completed.
02
Drugs
misoprostol
03
Conditions
intrauterine fetal demise (IUFD)
Beyond the preview
Go deeper on NCT00671060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00671060.